Ikonisys publishes its 2023 half-year financial results and reviews its operational and strategic deployments Expansion of the market outside of the US.
A year marked by significative strategic investments and by the first sale of the Ikoniscope20 solution, including newly added reagents in partnership with Empire Genomics, to the first US customer
Ikonisys publishes its Full-Year Financial Results for 2022 and provides an update on its latest developments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.